Literature DB >> 23222947

Congenital infection by Trypanosoma cruzi in an endemic area of Chile: a multidisciplinary study.

Werner Apt1, Inés Zulantay, Marcela Arnello, David Oddó, Sandra González, Jorge Rodríguez, Ulrike Kemmerling, Carine Truyens, Yves Carlier.   

Abstract

BACKGROUND: This study investigated the prevalence of Chagas disease (ChD) in pregnant women in Choapa Province (IV Region, Chile) and the vertical transmission of Trypanosoma cruzi.
METHOD: ELISA and IFI IgG for ChD was performed for the pregnant women. PCR for T. cruzi was done for all chagasic mothers and their newborns. The congenital infection was confirmed by serial positive PCR and/or ELISA or IFI IgG after age of nine months. The placentas of mothers, with and without ChD, were submitted for histopathology and immunohistochemical study.
RESULTS: From 4831 deliveries in 2005-2009 with a serological coverage of 88.6%, it was established that 147 cases (3.4%) had ChD. More than 80% of the pregnancies had a physiological evolution and 90% of the newborn were term. Congenital transmission was demonstrated in six children (4.7%) of the 127 newborn studied by serial PCR (at birth and/or between 3-18 months) and/or ELISA or IIF IgG after age nine months. Most of congenital cases were asymptomatic (67%). The histopathology shows edema, necrosis, fibrinoid deposit in the placentas of 28 of 29 chagasic mothers. In three cases the immnunochemistry demonstrated a decrease in actin expression in trophoblast cells. In one congenital case amastigote nests was observed.
CONCLUSIONS: These results indicate that T. cruzi infection in pregnant women and vertical transmission in Chile are still prevalent. For this reason it is important to propose control measures in endemic areas of the country.

Entities:  

Mesh:

Year:  2012        PMID: 23222947     DOI: 10.1093/trstmh/trs013

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

Review 1.  Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease.

Authors:  Louisa A Messenger; Michael A Miles; Caryn Bern
Journal:  Expert Rev Anti Infect Ther       Date:  2015-08       Impact factor: 5.091

2.  Autochthonous transmission of Chagas disease in Rio de Janeiro State, Brazil: a clinical and eco-epidemiological study.

Authors:  Luiz Henrique Conde Sangenis; Roberto Magalhães Saraiva; Ingebourg Georg; Liane de Castro; Valdirene dos Santos Lima; André Luiz R Roque; Samanta Cristina das Chagas Xavier; Laura Cristina Santos; Fabiano A Fernandes; Otília Sarquis; Marli Maria Lima; Filipe Aníbal Carvalho-Costa; Márcio Neves Bóia
Journal:  BMC Infect Dis       Date:  2015-01-08       Impact factor: 3.090

3.  Epidemiology of congenital Chagas disease 6 years after implementation of a public health surveillance system, Catalonia, 2010 to 2015.

Authors:  Luca Basile; Pilar Ciruela; Ana Requena-Méndez; Mª José Vidal; Eva Dopico; Andrea Martín-Nalda; Elena Sulleiro; Joaquim Gascon; Mireia Jané
Journal:  Euro Surveill       Date:  2019-06

4.  A family cluster of Chagas disease detected through selective screening of blood donors: A case report and brief review.

Authors:  Guillaume Mongeau-Martin; Momar Ndao; Michael Libman; Gilles Delage; Brian J Ward
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 May-Jun       Impact factor: 2.471

Review 5.  Chagas' disease: pregnancy and congenital transmission.

Authors:  Ana María Cevallos; Roberto Hernández
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

Review 6.  Acute chagas disease: new global challenges for an old neglected disease.

Authors:  Daniela V Andrade; Kenneth J Gollob; Walderez O Dutra
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31

7.  Trypanosoma cruzi infection in puerperal women and their neonates at Barcelona, Anzoategui State, Venezuela

Authors:  Norielis Del Carmen Zabala; Mariolga Berrizbeitia; Alicia Jorquera; Jessicca Rodríguez; Leomery Romero
Journal:  Biomedica       Date:  2019-12-01       Impact factor: 0.935

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.